US Dollar vs Yen

登録して無料でリアルタイムの株価、インタラクティブチャート、ライブオプションフローなどを入手してください。

登録

ホーム
投資
株式
アメリカ
NASDAQ
Design Therapeutics Inc (DSGN)
Design Therapeutics Inc (DSGN) ニュース

DSGN

Design Therapeutics (DSGN)

Design Therapeutics Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:DSGN

1 2 3 4 5 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2025/03/10	20 : 30	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:DSGN	Design Therapeutics Inc
2025/03/10	20 : 16	Edgar (US Regulatory)	Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]	NASDAQ:DSGN	Design Therapeutics Inc
2025/03/10	20 : 10	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:DSGN	Design Therapeutics Inc
2025/03/10	20 : 07	GlobeNewswire Inc.	Design Therapeutics Highlights Progress Across Lead GeneTAC® Programs and Reports Fourth Quarter and Full Year 2024 Financial Results	NASDAQ:DSGN	Design Therapeutics Inc
2025/03/03	22 : 00	GlobeNewswire Inc.	Design Therapeutics to Participate in Leerink’s Global Healthcare Conference	NASDAQ:DSGN	Design Therapeutics Inc
2025/02/08	06 : 16	Edgar (US Regulatory)	Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]	NASDAQ:DSGN	Design Therapeutics Inc
2025/02/08	06 : 15	Edgar (US Regulatory)	Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]	NASDAQ:DSGN	Design Therapeutics Inc
2025/01/13	23 : 09	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:DSGN	Design Therapeutics Inc
2025/01/07	09 : 00	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:DSGN	Design Therapeutics Inc
2025/01/07	09 : 00	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:DSGN	Design Therapeutics Inc
2024/12/20	08 : 30	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:DSGN	Design Therapeutics Inc
2024/11/13	22 : 00	GlobeNewswire Inc.	Design Therapeutics to Participate in Multiple Upcoming Investor Conferences	NASDAQ:DSGN	Design Therapeutics Inc
2024/11/08	06 : 06	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:DSGN	Design Therapeutics Inc
2024/11/08	06 : 01	GlobeNewswire Inc.	Design Therapeutics Announces Third Quarter 2024 Financial Results and Reviews Near-term Milestones for GeneTACTM Portfolio	NASDAQ:DSGN	Design Therapeutics Inc
2024/09/10	21 : 00	GlobeNewswire Inc.	Design Therapeutics to Participate in the 2024 Cantor Global Healthcare Conference	NASDAQ:DSGN	Design Therapeutics Inc
2024/08/13	05 : 30	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:DSGN	Design Therapeutics Inc
2024/08/10	05 : 20	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:DSGN	Design Therapeutics Inc
2024/08/05	21 : 12	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:DSGN	Design Therapeutics Inc
2024/08/05	21 : 01	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:DSGN	Design Therapeutics Inc
2024/08/05	21 : 00	GlobeNewswire Inc.	Design Therapeutics Announces Second Quarter 2024 Financial Results and Reviews Near-term Milestones for GeneTAC™ Portfolio	NASDAQ:DSGN	Design Therapeutics Inc
2024/06/18	06 : 00	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:DSGN	Design Therapeutics Inc
2024/06/18	06 : 00	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:DSGN	Design Therapeutics Inc
2024/06/18	05 : 12	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:DSGN	Design Therapeutics Inc
2024/05/09	05 : 31	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:DSGN	Design Therapeutics Inc
2024/05/09	05 : 09	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:DSGN	Design Therapeutics Inc
2024/05/09	05 : 05	GlobeNewswire Inc.	Design Therapeutics Announces First Quarter 2024 Financial Results and Highlights Upcoming Program Milestones	NASDAQ:DSGN	Design Therapeutics Inc
2024/05/07	19 : 30	GlobeNewswire Inc.	Design Therapeutics to Participate in the 2024 RBC Capital Markets Global Healthcare Conference	NASDAQ:DSGN	Design Therapeutics Inc
2024/03/20	05 : 01	GlobeNewswire Inc.	Design Therapeutics Outlines Progress Across GeneTAC™ Platform and Announces Fourth Quarter and Full Year 2023 Financial Results	NASDAQ:DSGN	Design Therapeutics Inc
2024/03/19	20 : 27	IH Market News	US Index Futures Decline Ahead of Federal Reserve Meeting, Oil Prices Retreat	NASDAQ:DSGN	Design Therapeutics Inc
2024/03/12	19 : 30	GlobeNewswire Inc.	Design Therapeutics to Webcast Fourth Quarter and Full Year 2023 Financial Results and Comprehensive Portfolio Update	NASDAQ:DSGN	Design Therapeutics Inc

Showing the most relevant articles for your search:NASDAQ:DSGN

1 2 3 4 5 次へ >>

Daimler International Fi...

Goldman Sachs Marketbeta...

Globalworth Real Estate ...

S&p Midcap 400 Dividend ...

Republic of Finland

Societe Generale Effekten

Barclays Bank Plc Autoca...

United States of America

Rabobank UA cooperative

Ausnet Services Holdings...

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約